NeoGenomics Laboratories · 1 month ago
Temporary, Billing Reimbursement Specialist II
United States
Full-time
Remote
Entry, Mid Level
2+ years expNeoGenomics Laboratories is a company committed to improving patient care through exceptional work. They are seeking a Billing Reimbursement Specialist II responsible for reconciling medical claims and working with third-party insurance bills to collect revenue.
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Responsibilities
Focus efforts on increasing cash and reducing bad debt
Understands the various NeoGenomics products and tests and can present reasonable arguments for medical necessity on behalf of the patient in order to obtain coverage from the insurance payer
Appeals and denial management based on payer guidelines in a timely manner
Knowledge of reading and understanding of EOB’s
Evaluate and respond to all aspects of written billing inquiries from the patient or their representative in order to resolve billing issues
Review and work various reports including aging
Ability to understand and interpret advice/remark codes from payers
Data entry, correct payer assignment to patient accounts, insurance eligibility verification. Review/update demographics and patient information for accuracy
Investigate all denied services to determine the reason for the service denial and take the next appropriate action as necessary
Additional Responsibilities (may be assigned)
Qualification
Required
High School Diploma at minimum required
2 years of experience in A/R, Billing, insurance or healthcare
Working knowledge of appropriate coding systems; CPT, ICD-10 and HCPCS, coverage; LCD/NCD and Payer Medical Policies associated with such codes
Proficient in Microsoft Outlook, Excel, Word, the Inter and Intranet and other programs/software as necessary
Working knowledge and hands-on experience of medical billing and reimbursement
Preferred
a background in Laboratory insurance billing
Company
NeoGenomics Laboratories
NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$925.9M2021-05-05Post Ipo Equity· $200M
2020-04-30Post Ipo Equity· $125.4M
2020-04-30Post Ipo Debt· $175M
Leadership Team
Ravi Ada
Chief Technology Officer, Informatics Division
George A. Cardoza
Chief Financial Officer
Recent News
2026-01-14
2026-01-13
2026-01-13
Company data provided by crunchbase